業(yè)務(wù)咨詢
中國(guó):
Email: marketing@medicilon.com.cn
業(yè)務(wù)咨詢專線:400-780-8018
(僅限服務(wù)咨詢,其他事宜請(qǐng)撥打川沙總部電話)
川沙總部電話: +86 (21) 5859-1500
海外:
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
Email:marketing@medicilon.com
十月美迪西將主辦2場(chǎng)線上直播,同時(shí)參與9場(chǎng)海內(nèi)外行業(yè)會(huì)議,期待與各位業(yè)內(nèi)同仁交流分享藥物研發(fā)新趨勢(shì)。
Join Medicilon at the 22nd San Diego Biopharma Conference in the beautiful San Diego.
This time, you can not only visit our table, but also focus the speech “Medicilon Drug Discovery Cutting Edge Technology Platforms” by President of Medicilon USA Corp., Dr. Qingcong Lin.
We are excited to announce that Medicilon will exhibit at the Applied Pharmaceutical Analysis (APA) 2024 in Cambridge, MA. We are happy to meet you in person to discuss how our services and capabilities can support your research and expedite your drug discovery and development activities.
Dr. Peggy Teng, Executive Director BD Operations of MEDICILON USA CORP., will give a speaking at 2:25 - 3:05 local time on October 8. We sincerely invite you to visit us at Medicilon Booth #3!
This time let's meet in San Francisco!
16th Drug Discovery Strategic Summit is coming! Medicilon team will be present throughout the conference. We look forward to meeting you. Medicilon is experienced with oncology drug in any preclinical phases, from hit-to-lead to IND. We provide integrated service strategies for sponsors' oncology drug discovery and development pipelines. We aim to enhance every step in preclinical search and to deliver real time data.
(進(jìn)入會(huì)議官網(wǎng):https://jcd-expo.jp/en/,了解更多)
本次大會(huì)將于今年10月9日至11日在日本橫濱市的PACIFICO Yokohama舉行。
美迪西團(tuán)隊(duì)將在B-82全程設(shè)展,誠(chéng)邀您蒞臨現(xiàn)場(chǎng)一對(duì)一交流!
The 46th Korean Society of Nonclinical Study (KSNS) Workshop is only two weeks to go! Medicilon is excited to exhibit in the conference. Dr. Hanjun Zou, TFM of Medicilon Chuansha site, and Medicilon KoreanTeam will be available at Medicilon Booth #43. Dr. Zou has more than 17 years of experience in toxicity and preclinical safety assessment with most career working in multinational companies. Dr. Zou is also a certified toxicologist (DCST, ERT & DABT) in China, Europe and the United States.
We are getting ready. Are you?
2024年10月18日-20日,一年一度的國(guó)際生物醫(yī)藥大會(huì)——2024中國(guó)(天津)國(guó)際生物醫(yī)藥產(chǎn)業(yè)博覽會(huì)(BIOME2024)將在國(guó)家會(huì)展中心(天津)舉辦。
美迪西將在現(xiàn)場(chǎng)設(shè)展,誠(chéng)邀您蒞臨交流!
Troubled by your current problems with drug discovery? Meet Medicilon at AAPS 2024 PHarmSCi 360! It kicks off on October 20 in Salt Lake City. Medicilon team will be present in person at Medicilon Booth #1526! Maybe Medicilon can help you solve your current problem and become a partner of choice! Medicilon is continuedly advancing our technology platforms constantly, collaborating closely with our global clients to deliver demanding and innovative novel drug research.
Medicilon is thrilled to exhibit in the 17th Drug Discovery Strategic Summit. The summit will take place from 23 to 24 October 2024 at Munich, Germany. Dr. Paul van Stralen, VP of Strategic Collaborations EMEA at Medicilon, will be available throughout the conference. We invite you to visit us at Medicilon Booth #6 to explore our services and capabilities.
為進(jìn)一步推動(dòng)溶瘤病毒藥物臨床研發(fā),促進(jìn)溶瘤病毒領(lǐng)域全鏈條交流與合作,由中國(guó)醫(yī)藥創(chuàng)新促進(jìn)會(huì)、武漢東湖新技術(shù)開(kāi)發(fā)區(qū)管理委員會(huì)、艾美達(dá)醫(yī)藥咨詢和濱會(huì)生物等機(jī)構(gòu)共同組織的第二屆溶瘤病毒創(chuàng)新與合作大會(huì)定于2024年10月26~27日在湖北武漢舉行。
美迪西團(tuán)隊(duì)將在B20展位設(shè)展,誠(chéng)邀您蒞臨交流!美迪西首席科學(xué)官彭雙清將在現(xiàn)場(chǎng)發(fā)表演講!
marketing@medicilon.com.cn
媒體與會(huì)務(wù)請(qǐng)聯(lián)系
美迪西市場(chǎng)部微信或郵箱